Pramanik Subhodip, Mondal Sunetra, Palui Rajan, Ray Sayantan
Department of Endocrinology, Neotia Getwel Multi-specialty hospital, Siliguri 734010, West Bengal, India.
Department of Endocrinology, NRS Medical College and Hospital, Kolkata 700014, West Bengal, India.
World J Clin Pediatr. 2024 Jun 9;13(2):91587. doi: 10.5409/wjcp.v13.i2.91587.
Over the past 20 years, the incidence and prevalence of type 2 diabetes mellitus (T2DM) in children and adolescents have increased, particularly in racial and ethnic minorities. Despite the rise in T2DM in children and adolescents, the pathophysiology and progression of disease in this population are not clearly understood. Youth-onset T2DM has a more adverse clinical course than is seen in those who develop T2DM in adulthood or those with T1DM. Furthermore, the available therapeutic options are more limited for children and adolescents with T2DM compared to adult patients, mostly due to the challenges of implementing clinical trials. A better understanding of the mechanisms underlying the de-velopment and aggressive disease phenotype of T2DM in youth is important to finding effective prevention and management strategies. This review highlights the key evidence about T2DM in children and adolescents and its current burden and challenges both in clinical care and research activities.
在过去20年中,儿童和青少年2型糖尿病(T2DM)的发病率和患病率有所上升,尤其是在少数种族和族裔群体中。尽管儿童和青少年T2DM发病率有所上升,但该人群疾病的病理生理学和进展情况仍未完全明确。青少年发病的T2DM临床病程比成年后发病的T2DM患者或1型糖尿病(T1DM)患者更为不利。此外,与成年患者相比,T2DM儿童和青少年可用的治疗选择更为有限,这主要是由于开展临床试验面临的挑战。更好地了解青少年T2DM发生发展及侵袭性疾病表型背后的机制,对于寻找有效的预防和管理策略至关重要。本综述重点介绍了儿童和青少年T2DM的关键证据及其在临床护理和研究活动中的当前负担与挑战。